GLP-1 Medications are too powerful to prescribe over chat
GLP-1 Medications are
too powerful to prescribe
over chat
GLP-1 medications require expert guidance. Unsupervised GLP-1 use has been shown to cause substantial muscle loss and worse rebound weight gain after use. Both can lead to future health issues. We support you physically and mentally — so you can shed weight safely while adapting and thriving through your transformation.
Average amount of weight lost using GLP-1 medications is 18-22%, depending on the specific drug
Reduction of common side effects experienced by our patients due to our precision dosing, which also reduces serious side effects by 10%
Amount of weight lost in lean body mass due to GLP-1 drugs
How GLP-1 Medications work
Based on your unique biology and needs, your Aayu Well physician will decide which drug will be best for you. The drugs in this class include Ozempic®, Wegovy®, Zepbound®, and Mounjaro®. All are administered by injection.
Increases fat burning- Improves glucose uptake
- Decreases glucose production and output to blood
- reduces fat storage in the liver cells
- Increases glucose utilization
- Improves blood flow
- Slows down the emptying of the stomach by reducing montility
- Reduces acid secretion
- Improves hormonal secretions and leads to improved blood glucose levels. [Improved insulin secretion, reduces glucagon secretion]
- Grows insulin-producing cells in the pancreas. [Beta cells]
- Appetite regulation
- Reduction in substance seeking behaviors
- Potential impact on cognitive functions
- Better glucose utilization
- Dilates blood vessels and increases cardiac output
- Reduced fatty acid metabolis
- Reduces inflammation
- Improves gut heath
- Reduces risk of heart disease in high risk patients
The many
benefits of GLP-1 Medications
Glucagon Like Peptides-1 (GLP-1) Agonist medications, originally developed for Type 2 diabetes, have shown to have a number of other potential benefits, particularly in managing obesity.
Lowers blood pressure- Improves fatty liver disease and liver inflammation
- Obesity can lead to heart diseases like high blood pressure and heart attacks, as excess fat strains the heart and clogs blood vessels.
- Guts: Reduces the pro-inflammatory cytokines in the guts.
- Heart: Reduces vascular inflammation and oxidative stress by improving endothelial function
- Brain: Improves inflammatory markers in brain and could improve the risk of Alzheimer’s*
- Reduces overeating
- Improves alcohol consumption-related behaviors
- Weight loss reduces wear and tear on weight bearing joints
- Can improve joint aches and pains
- Weight loss significantly improves obstructive sleep apnea
- Improves energy levels
Available GLP-1 Medications In The U.S.
Glucagon-Like Peptide-1 (GLP-1) agonist medications are approved for the treatment of Obesity and Type 2 Diabetes Mellitus under various brand names.
Saxenda (Liraglutide)
Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.
Wegovy (Semaglutide)
Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.
Mounjaro (Tirzepatide)
Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.
Rybelsus (Semaglutide)
Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.
Trulicity® (Dulaglutide)
Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.
Saxenda (Liraglutide)
Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.
Saxenda (Liraglutide)
Ozempic® (semaglutide) is a medication primarily used for managing type 2 diabetes in adults and for lowering the risk of major cardiovascular events, such as stroke, heart attack, or death in adults with type 2 diabetes who have heart disease. It's not currently FDA-approved for weight loss, but clinical trials have shown effectiveness in this area as well.
Side effects: Minimized
GLP-1 medications can have serious side effects, especially with unsupervised use, but with experienced use and precise dosing, Aayu Well’s focus on safety will minimize adverse reactions.
Common side effects
Gastrointestinal discomfort (nausea, vomiting, diarrhea, abdominal pain, constipation), appetite changes, dizziness, and reactions at the injection site.
Serious concerns
Hypoglycemia (notably with other diabetes drugs), increased heart rate, hypotension, and anxiety.
Rare risks
Potential for thyroid cancer, pancreatitis, complications with diabetic retinopathy, allergic reactions, and kidney or liver issues.
START the change TODAY